Accelerate Diagnostics
- Country
- Ownership
- -
- Employees
- 134
- Market Cap
- -
- Introduction
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Accelerate Diagnostics Seeks FDA Clearance for Rapid Antimicrobial Susceptibility Testing System
Accelerate Diagnostics has submitted its WAVE system and gram-negative test kit to the FDA for 510(k) clearance, designed to deliver antimicrobial susceptibility results in just 4.5 hours.
Accelerate Diagnostics' Accelerate Arc System Receives FDA Clearance for Rapid Microbial Identification
The FDA has cleared Accelerate Diagnostics' Accelerate Arc system for rapid microbial identification from positive blood cultures, aiding in sepsis management.